Fig. 1From: Association between fasting blood glucose levels at admission and overall survival of patients with pancreatic cancerKaplan-Meier survival curve. The median survival in the normal glucose group was 20.5 months (95% confidence interval (CI): 14.2–26.9). The median survival in the abnormal glucose group was 14.2 months (95% CI: 9.7–18.6). There was no statistically significant difference between the two groups (P = 0.573)Back to article page